A Clinical Study on LM103 Injection for the Treatment of Advanced Solid Tumors
Clinical trial NCT05971589 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05971589
- Sponsor
- Suzhou BlueHorse Therapeutics Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2026-04-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.